Not all the speculation has been cautionary, of course: Morgan Stanley analysts suggest overall healthcare savings associated with GLP-1-related weight loss could top $264 billion by 2035
For patients who prefer brand medications or have insurance coverage, telehealth providers can also prescribe Wegovy, Ozempic, Mounjaro, and Zepbound
Enhanced energy, better sleep, and reduced stigma or self-blame about weight can positively affect self-esteem and social engagement
Patients with lupus nephritis who are using GLP-1 receptor agonists have a reduced risk of mortality, acute myocardial infarctions, and a decreased rate of progression of chronic kidney disease in comparison to patients who were using SGLT2 inhibitors, Grzybowski said
Understanding endogenous GLP-1 production matters because supporting your body's natural secretion may complement metabolic health strategies